AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ENDRA Life Sciences Inc. Director's Dealing 2020

Jan 6, 2020

Director's Dealing

Opens in your device viewer

Issuer: ENDRA Life Sciences Inc. (NDRA)
CIK: 0001681682
Period of Report: 2020-01-02

Reporting Person: DIGIANDOMENICO ANTHONY (Director)

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-01-02	Stock Options	$1.90	A	12000	Acquired	2030-01-02	Common Stock (12000)	Direct

F1: Represents a stock option award granted on January 2, 2020 pursuant to the Issuer's Non-Employee Director Compensation Policy.